Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine. 1987

R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti

Four patients with human-immuno-deficiency-virus-associated neurological disease were treated with 3'-azido-3'-deoxythymidine (AZT). Three (two with chronic dementia, and one with chronic dementia and peripheral neuropathy) improved as assessed by clinical examination, psychometric tests, nerve conduction studies, and/or positron emission tomography; there was no improvement in the fourth patient who presented with paraplegia. These results support the hypothesis that certain AIDS-virus-associated neurological abnormalities are reversible by antiretroviral chemotherapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
January 1990, Reviews of infectious diseases,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
January 1991, Journal of virology,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
June 1989, Antimicrobial agents and chemotherapy,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
May 1992, Antiviral research,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
February 1988, Antimicrobial agents and chemotherapy,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
March 1995, Journal of virology,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
June 1990, Antimicrobial agents and chemotherapy,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
October 1990, AIDS research and human retroviruses,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
October 1990, Biochemical and biophysical research communications,
R Yarchoan, and G Berg, and P Brouwers, and M A Fischl, and A R Spitzer, and A Wichman, and J Grafman, and R V Thomas, and B Safai, and A Brunetti
May 1989, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!